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The Plasmodium falciparum ATPase PfATP4 is the target of a
diverse range of antimalarial compounds, including the clinical
drug candidate cipargamin. PfATP4 was originally annotated as
a Ca2 transporter, but recent evidence suggests that it is a Na
efflux pump, extruding Na in exchange for H. Here we dem-
onstrate that ATP4 proteins belong to a clade of P-type ATPases
that are restricted to apicomplexans and their closest relatives.
We employed a variety of genetic and physiological approaches
to investigate the ATP4 protein of the apicomplexan Toxo-
plasma gondii, TgATP4. We show that TgATP4 is a plasma
membrane protein. Knockdown of TgATP4 had no effect on
resting pH or Ca2 but rendered parasites unable to regulate
their cytosolic Na concentration ([Na]cyt). PfATP4 inhibitors
caused an increase in [Na]cyt and a cytosolic alkalinization in
WT but not TgATP4 knockdown parasites. Parasites in which
TgATP4 was knocked down or disrupted exhibited a growth
defect, attributable to reduced viability of extracellular para-
sites. Parasites in which TgATP4 had been disrupted showed
reduced virulence in mice. These results provide evidence for
ATP4 proteins playing a key conserved role in Na regulation in
apicomplexan parasites.
The Apicomplexa are a phylum of unicellular parasitic pro-
tists that impose enormous medical, veterinary, and socioeco-
nomic burdens. Members of this phylum include Plasmodium,
multiple species of which cause malaria in humans, and Toxo-
plasma gondii, the causative agent of toxoplasmosis. Apicom-
plexan parasites have complex life cycles that involve intracel-
lular and extracellular stages, often in at least two different host
organisms, in which they encounter vastly different external
environments. To survive, they must regulate their cytosolic
Na concentration ([Na]cyt) and pH (pHcyt) in the face of
widely varying external ionic conditions. How they accomplish
this is not well understood.
Cells typically control their [Na]cyt and pHcyt tightly, using
a variety of membrane transporters and channels to do so. Dif-
ferences between extracellular and intracellular Na and H
concentrations (i.e. ion gradients) are exploited for essential
processes such as nutrient acquisition and cell volume regula-
tion. In most cell types, the cytosol is typically slightly alkaline
(pH 7.2–7.3), and the [Na]cyt is typically around 10 mM
(1, 2).
Most studies of Na and pH regulation in apicomplexan par-
asites to date have been performed with the blood-stage form of
the most virulent human malaria parasite, Plasmodium falcip-
arum. This parasite has, on its plasma membrane, a H-extrud-
ing V-type ATPase that plays a key role in pH regulation (3, 4)
while also generating a large, inwardly negative membrane
potential (5). The extracellular tachyzoite form of T. gondii has
also been shown to have a plasma membrane V-type H-
ATPase that plays roles both in controlling pHcyt and generat-
ing and maintaining the membrane potential (6).
Na regulation in apicomplexan parasites has recently
emerged as an area of particular interest. In an attempt to iden-
tify the target of a promising new class of antimalarials, the
“spiroindolones,” P. falciparum parasites were exposed to
increasing sublethal doses of these drugs in vitro until parasites
showing low-level resistance emerged. Resistant parasites were
found to have mutations in PfATP4, a gene encoding a plasma
membrane P-type ATPase (7). PfATP4 was originally anno-
tated as a Ca2 transporter (8); however, there are now multiple
lines of evidence that the transporter mediates the efflux of Na
from the parasite. First, antiplasmodial spiroindolones (of
which cipargamin, formerly known as NITD609 and KAE609,
is the clinical candidate) cause a rapid increase in the parasite’s
[Na]cyt and Na content (9 –11). The same is true of a range of
structurally unrelated antiplasmodial agents for which muta-
tions in PfATP4 confer resistance (12–15). Second, spiroin-
dolone-resistant parasites with mutations in PfATP4 are less
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sensitive to the disruption of [Na]cyt by spiroindolones and
also have a higher resting [Na]cyt, consistent with resistance-
conferring mutations in PfATP4 causing some impairment of
its Na transport function (10, 13). Third, spiroindolones
inhibit Na-dependent ATPase activity in parasite membrane
preparations (10, 16, 17).
In addition to dissipating the Na gradient across the plasma
membrane of the malaria parasite, spiroindolones and other
“PfATP4-associated” antimalarials cause an increase in pHcyt,
increasing the pH gradient across the parasite plasma mem-
brane (10, 13–16, 18). PfATP4 has been postulated to expel Na
from the parasite in exchange for H, imposing a significant
“acid load” on the parasite (19). Lifting this load by inhibiting
PfATP4 results in a cytosolic alkalinization.
The disruption of ion regulation by the PfATP4-associated
antimalarials triggers a variety of detrimental events in the par-
asite (9, 20). It is not known whether ATP4 homologues in other
apicomplexan parasites are similarly vulnerable.
Little is known about Na regulation in T. gondii. The
plasma membrane of T. gondii harbors two candidate Na/H
exchangers, TgNHE1 and TgNHE4 (21, 22). pHcyt is unaffected
by the removal of extracellular Na (6) and is unchanged in
mutant parasites lacking a functional TgNHE1 (21), consistent
with TgNHE1 not playing a significant role in the maintenance
of the parasite’s resting pHcyt. TgNHE1 mutant parasites have
an elevated [Ca2]cyt, suggesting a role for TgNHE1 in Ca2
regulation, perhaps via an effect on [Na]cyt (21). However, the
[Na]cyt of T. gondii has not been studied directly. The antima-
larial spiroindolone cipargamin has been shown to inhibit the
growth of T. gondii (23), raising the possibility that the T. gondii
homolog of ATP4 (TgATP4) may play an important role in this
parasite. However, neither the function of TgATP4 nor the sen-
sitivity of TgATP4 to cipargamin have been investigated.
In this study, we used a combination of genetic and physio-
logical approaches to provide evidence that TgATP4 is a plasma
membrane Na pump that is important for Na homeostasis,
particularly in extracellular parasites that encounter high
[Na], and sensitive to a number of compounds that are
believed to target PfATP4.
Results
The apicomplexan ATP4 proteins form a distinct subfamily of
type II P-type ATPases
TgATP4 (TGME49_278660) shares significant sequence
similarity with PfATP4 (Fig. S1). TgATP4 and PfATP4 both
contain the eight semiconserved regions that have been
described as comprising the “core of the P-type ATPase super-
family” (24), as well as the PROSITE consensus sequence for the
phosphorylation site of P-type ATPases, D-K-T-G-T-[LIVM]-
[TI] (Fig. S1). PfATP4 belongs to the type II branch of P-type
ATPases (24), which includes ATP-driven Ca2, Na, K, and
H transporters. Type II P-type ATPases have been previously
divided into four subgroups (A–D) based on a phylogenetic
analysis of their 265-residue “core” region (24). Type IIA and
type IIB P-type ATPases transport Ca2, whereas type IIC
P-type ATPases include Na/K transporters and H/K
transporters (24). Type IID P-type ATPases are “exitus natrus”
(ENA)6 transporters that have been proposed to extrude Na
(24).
We performed a phylogenetic analysis of type II P-type
ATPases with a dataset consisting of TgATP4; PfATP4; other
type II P-type ATPases from T. gondii, P. falciparum, and other
apicomplexans; and type II P-type ATPases from a range of
other eukaryotes, including other members of the Alveolata
(ciliates, dinoflagellates, and chromerids), the superphylum of
eukaryotes to which apicomplexans belong. Our analysis
revealed four previously defined subgroups of type II P-type
ATPases (24) plus a fifth subgroup of proteins, referred to here
as “ATP4-type ATPases” (Fig. 1). The ATP4-type ATPase sub-
group has strong bootstrap support and includes TgATP4,
PfATP4, and proteins from all other apicomplexans we exam-
ined. We also identified ATP4-type ATPases in the chromerids
Vitrella brassicaformis and Chromera velia and in the dinofla-
gellate Symbiodinium minutum. Chromerids and dinoflagel-
lates are the closest extant relatives of apicomplexans (25, 26),
and the presence of ATP4-type ATPases encoded in the
genomes of these organisms suggests that ATP4-type ATPases
evolved before these three lineages diverged. The absence of
ATP4-type ATPases in other eukaryotes suggests that this fam-
ily of proteins is restricted to apicomplexans and closely related
organisms.
TgATP4 localizes to the T. gondii plasma membrane and is
important for parasite growth
To examine the expression and localization of TgATP4, we
fused a HA tag to the 3 end of the ORF of the gene. Western
blotting revealed that the resultant TgATP4-HA protein had an
approximate mass of 160 kDa (Fig. 2A), close to the predicted
mass of 147 kDa for HA-tagged TgATP4. Immunofluorescence
assays revealed that TgATP4 co-localized with a marker for the
plasma membrane (P30; 27) (Fig. 2B).
To determine whether TgATP4 is important for T. gondii
growth, we generated a TgATP4 inducible knockdown line in
which the native TgATP4 promoter was replaced with an anhy-
drotetracycline (ATc)-regulated promoter, and the resultant
protein was fused with an N-terminal HA tag (Fig. S2, A and B).
We refer to this strain as “iHA-TgATP4.” We confirmed local-
ization of the HA-TgATP4 protein to the plasma membrane in
this strain (Fig. S2C).
Exposure of iHA-TgATP4 parasites to ATc led to down-reg-
ulation of HA-TgATP4 expression, with the protein becoming
nearly undetectable by Western blotting (Fig. 2C) and in immu-
nofluorescence assays (Fig. S2C) 2 days after the addition of
ATc. To determine whether TgATP4 is important for parasite
growth and survival, we introduced the bright tandem dimeric
Tomato (tdTomato) red fluorescent protein into the iHA-
TgATP4 strain (creating a strain we termed “iHA-TgATP4/To-
mato”), allowing us to monitor parasite growth fluorometrically
using an assay described previously (28). Addition of ATc at the
start of the assay resulted in a decrease in the growth of iHA-
6 The abbreviations used are: ENA, exitus natrus; ATc, anhydrotetracycline;
ANOVA, analysis of variance; gRNA, guide RNA; SBFI, sodium-binding ben-
zofuran isophthalate; BCECF, 2’,7’-bis-(2-carboxyethyl)-5-(and-6)-carboxy-
fluorescein; IFA, immunofluorescence assay.
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TgATP4/Tomato parasites (p  0.05, one-way ANOVA; Fig.
2D) but not in that of Tomato-expressing WT (“WT/Tomato”)
parasites (p  0.05, one-way ANOVA; Fig. 2D). Addition of
ATc to iHA-TgATP4/Tomato parasites 3 days before com-
mencing the assay (and maintaining its presence throughout
the assay) further exacerbated the growth defect (p  0.05, one-
way ANOVA; Fig. 2D). To determine whether these growth
defects were specifically the result of TgATP4 knockdown, we
complemented iHA-TgATP4/Tomato parasites with constitu-
tively expressed Ty1-tagged TgATP4 (generating a strain we
termed “iHA-TgATP4/Tomato/cTy1-TgATP4”). This restored
parasite growth in the presence of ATc (Fig. 2D), indicating that
the growth phenotype observed in the iHA-TgATP4/Tomato
strain resulted exclusively from the lack of expression of
TgATP4.
The requirement for TgATP4 expression at different stages
of the lytic cycle of T. gondii was investigated using a series of
assays. First we investigated whether TgATP4 expression was
important for the growth of intracellular parasites. iHA-TgATP4/
Tomato parasites and WT/Tomato parasites were incubated with
or without ATc for 2 days, extracted from their host cells, and
allowed to invade new host cells for 24 h. The number of parasites
per host cell vacuole was then determined. Most vacuoles con-
tained either eight or 16 parasites at this time point (Fig. 3A), and
there were no significant differences in the percentage of host cell
vacuoles having any given number of parasites between WT/To-
mato and iHA-TgATP4/Tomato parasites or between ATc-
treated and untreated parasites (p  0.05, one-way ANOVA).
These data suggest that TgATP4 expression is not required for the
intracellular growth or division of T. gondii.
Figure 1. Phylogenetic analysis of TgATP4. A phylogenetic tree of type II P-type ATPases shows the previously defined groups type IIA, B, C, and D and a new
group, the ATP4-type ATPases. The latter group, shaded in green, includes PfATP4 and TgATP4 (indicated by arrows). The tree was created using maximum
likelihood analysis of protein amino acid sequence using the phylogenetic software package PHYLIP. PMCA, plasma membrane Ca2 ATPase; SERCA, sarco/
endoplasmic reticulum Ca2-ATPase; SPCA, secretory pathway Ca2-ATPase.
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We next investigated whether knocking down TgATP4
impaired the ability of parasites to egress from their host cells.
The egress of parasites from their host cells was stimulated by
addition of the Ca2 ionophore A23187, and “percent egress”
(the percentage of individual parasitophorous vacuoles from
which parasites were observed to escape) was calculated as
described previously (29). No significant difference in the per-
cent egress was observed between WT and iHA-TgATP4 para-
sites or between parasites maintained for 30 h in the presence or
absence of ATc (Fig. 3B; p  0.05, one-way ANOVA).
To investigate whether TgATP4 is important for invasion,
WT/Tomato and iHA-TgATP4/Tomato parasites were
grown in the absence or presence of ATc for 2 days and then
allowed to invade host cells for 10 min. There was a small
apparent decrease in invasion of iHA-TgATP4/Tomato par-
asites grown in the presence of ATc (Fig. 3C), but this
decrease was not statistically significant (p  0.05, one-way
ANOVA). We conclude that the defect in overall parasite
growth observed upon TgATP4 knockdown (Fig. 2D) cannot
be explained by defects in invasion, egress, or intracellular
growth (Fig. 3, A–C).
In preliminary experiments, we observed that extracellular
iHA-TgATP4 parasites treated with ATc exhibited an altered,
rounded morphology and frequently contained a large intracel-
lular vacuole (Fig. S3). We considered whether iHA-TgATP4
knockdown resulted in decreased viability of extracellular par-
asites, as has been observed in mutants of a gene involved in
T. gondii stress responses (30). Parasites were grown in the
absence or presence of ATc for 2 days, mechanically released
from host cells by passage through a 26-gauge needle, and incu-
bated in standard growth medium (which has a high [Na]) for
0 –27 h. Parasites were then labeled for 20 min in propidium
iodide (a membrane-impermeant DNA dye frequently used to
assess cell viability; 31) and analyzed by flow cytometry. In all
cases, parasite viability declined over the 27-h incubation; how-
ever, the viability of iHA-TgATP4 parasites grown in the pres-
ence of ATc decreased more rapidly than that of iHA-TgATP4
parasites grown in the absence of ATc or of WT controls, with
statistical significance reached after a 20-h incubation in the
growth medium (Fig. 3D; n  4, p  0.003, one-way ANOVA).
In summary, TgATP4 is important for the growth of T. gondii
parasites over multiple lytic cycles and is not required for intra-
cellular growth, egress or invasion but is important for main-
taining the viability of extracellular parasites.
TgATP4-disrupted parasites show reduced virulence in mice
To investigate the impact of TgATP4 on parasite virulence in
vivo, we generated parasites in which the ORF of TgATP4 was
disrupted using CRISPR-Cas9 targeted genome editing. We
designed a single guide RNA (gRNA) that targeted the first exon
of the TgATP4 ORF (Fig. S4A) and transfected this into WT
RHhxgprt/Tomato parasites (32). We identified a clonal par-
asite strain with a 113-bp insertion in the TgATP4 locus, result-
ing in incorporation of a premature stop codon in the TgATP4
Figure 2. Localization of TgATP4 and the effect of down-regulating its expression on T. gondii growth. A, Western blotting of TgATP4-HA– expressing
parasites performed using an anti-HA antibody. B, immunofluorescence assay of TgATP4-HA protein (green) reveals co-localization with the plasma membrane
marker P30 (red). The scale bar represents 2 m. DIC, differential interference contrast. C, Western blotting of iHA-TgATP4 parasites grown for 0 –3 days on ATc.
Parasite protein extracts were probed with anti-HA (top) and anti-GRA8, an antibody against a dense granule protein, as a loading control (bottom). D, growth
of the WT/Tomato, iHA-TgATP4/Tomato, and iHA-TgATP4/Tomato/cTy1-TgATP4 parasites in the absence of ATc (black symbols), in the presence of ATc (from
day 0, red symbols), and in the presence of ATc from 3 days before the start of the assay (gray symbols). The data show the mean 	 S.D. of four independent
experiments. For each parasite line and day (from Day 1 onward), the growth under the three different conditions was compared using a one-way ANOVA with
blocking (see “Experimental procedures”). Statistically significant differences (p  0.05) were only observed for the iHA-TgATP4/Tomato parasite line. For this
line, the difference between the 
ATc and ATc since Day 
3 conditions was statistically significant from Day 2 onward, and the difference between the 
ATc
and ATc conditions was significant on Days 4 and 5. There was also a significant difference between the ATc and “ATc since Day 
3 conditions on Days
2, 4, 5, and 6.
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ORF (Fig. S4B). This strain will synthesize a truncated, and
likely nonfunctional, TgATP4 protein that lacks residues 34 to
1338. We termed this strain atp434 –1338. Plaque assays
revealed that atp434 –1338 parasites exhibited a growth defect
in vitro (Fig. S4C). Complementation of atp434 –1338 parasites
with a constitutively expressed copy of TgATP4 (yielding the
strain “atp434 –1338/cTy1-TgATP4”) rescued the in vitro
growth phenotype (Fig. S4C).
To determine whether TgATP4 influences parasite virulence
in vivo, we infected mice with either WT, atp434 –1338,
or atp434 –1338/cTy1-TgATP4 parasites. In each case, five
BALB/c mice were infected intraperitoneally with 103 parasites.
All mice infected with WT or atp434 –1338/cTy1-TgATP4 par-
asites exhibited symptoms of toxoplasmosis and were eutha-
nized on Day 6 or 7 post-infection (Fig. 4). In contrast, mice
infected with atp434 –1338 parasites did not display disease
symptoms until Day 9 or 10 post-infection (Fig. 4). Thus, para-
sites lacking TgATP4 can cause disease in vivo, but their viru-
lence is reduced.
Figure 4. Virulence of TgATP4-expressing and TgATP4-disrupted para-
sites in mice. Five BALB/c mice were infected with 103 WT (black),
atp434 –1338 (red), or atp434 –1338/cTy1-TgATP4 (blue) parasites and moni-
tored for progression of disease. The data are from a single experiment.
Figure 3. Investigation of the importance of TgATP4 for intracellular growth, egress, and invasion. A, to measure intracellular parasite growth,
WT/Tomato and iHA-TgATP4/Tomato parasites were grown in the presence and absence of ATc for 2 days. Parasites were allowed to invade host cells
and then cultured for 24 h before fixing the cells and counting the number of parasites per vacuole. B, the ability of WT and iHA-TgATP4 parasites
(maintained for 30 h in the presence or absence of ATc) to egress from their host cells after a 3-min exposure to the Ca2 ionophore A23187 (2 M). C,
WT/Tomato and iHA-TgATP4/Tomato parasites were grown in the absence and presence of ATc for 2 days and then allowed to invade host cells for 10
min. D, to measure extracellular parasite viability, WT and iHA-TgATP4 parasites were grown in the absence or presence of ATc for 2 days. Intracellular
parasites were then mechanically egressed from host cells and incubated as extracellular parasites in (high-[Na]) growth medium for 0 –27 h. The
viability of parasites was monitored at predetermined time points by labeling with propidium iodide. In A–C, the bars show the mean values (with the
error bars showing S.D.) averaged from three independent experiments. The data from individual experiments are shown with circles. In D, the data
shown are the mean values (	 S.D.) averaged from four independent experiments (asterisks denote statistically significant differences between
iHA-TgATP4 parasites incubated in the presence of ATc and all other parasites and conditions: **, p  0.01; ***, p  0.001; one-way ANOVA). Where not
shown, error bars fall within the symbols.
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TgATP4 is important for Na regulation in T. gondii
The addition of antimalarial spiroindolones or other com-
pounds believed to inhibit PfATP4 to isolated P. falciparum
parasites results in an immediate-onset, gradual increase in
both [Na]cyt and pHcyt (10, 12–16, 18) but no change in
[Ca2]cyt (10, 15). We investigated the role of TgATP4 in regu-
lating [Na]cyt, pHcyt, and [Ca2]cyt in T. gondii using the Na-
sensitive fluorescent indicator SBFI, the pH-sensitive fluores-
cent indicator BCECF, and the Ca2-sensitive fluorescent
indicator Fura-2, respectively. In each case, cultures containing
iHA-TgATP4 parasites were exposed to either ATc or 0.025%
(v/v) ethanol (solvent control) for 2 days leading up to the
experiment. On the day of the experiment, the appropriate flu-
orescent indicator was loaded into T. gondii tachyzoites that
had either recently emerged from their host cells or that had
been released from their host cells by passage of the culture
through a 26-gauge needle. The dyes are all ratiometric, and an
increase in the measured fluorescence ratio corresponds to an
increase in [Na]cyt (SBFI), pHcyt (BCECF), or [Ca2]cyt
(Fura-2).
We incubated iHA-TgATP4 parasites grown in the absence
of ATc (i.e. expressing TgATP4) in a saline solution containing
130 mM Na and measured the resting [Na]cyt. We found that
the resting [Na]cyt was less than 20 mM (Fig. 5A). Upon addi-
tion of cipargamin (50 nM; a concentration that has been used in
similar experiments with isolated P. falciparum parasites (16)),
the [Na]cyt in these parasites increased (Fig. 5A). The cipar-
gamin-induced increase in Na content in T. gondii parasites
was confirmed using an alternate, HPLC-based approach (Fig.
S5). In contrast, in iHA-TgATP4 parasites that had been
exposed to ATc for 2 days to knock down TgATP4 expression,
the resting [Na]cyt was 130 mM (i.e. close to the [Na] in the
medium in which the parasites were suspended; Fig. 5A). Cipar-
gamin had little effect on [Na]cyt in these parasites (Fig. 5A).
These data indicate that, as proposed for PfATP4, TgATP4
plays a key role in maintaining a low [Na]cyt in the parasite.
Our data are consistent with TgATP4 functioning as an Na
efflux pump and being inhibited by nanomolar concentrations
of cipargamin.
We next measured the effects of cipargamin and TgATP4
knockdown on resting pHcyt. We found that the resting pHcyt of
iHA-TgATP4 parasites grown in the absence or presence of
ATc was similar (7.33 	 0.09 and 7.40 	 0.08, respectively; p 
0.10, unpaired t test; mean 	 S.D.; n  8). However, iHA-
TgATP4 parasites expressing TgATP4 (
ATc), but not those
with TgATP4 knocked down (ATc), were found to undergo a
cytosolic alkalinization upon addition of 50 nM cipargamin (Fig.
5B). This is consistent with the hypothesis that TgATP4
extrudes Na in exchange for H, maintaining a low [Na]cyt
while at the same time imposing an acid load on the parasite.
Inhibition of TgATP4 results in a lifting of this load and conse-
quent cytosolic alkalinization.
The V-type H-ATPase inhibitor concanamycin A (100 nM)
resulted in a cytosolic acidification in parasites that had been
maintained both with () or without (
) ATc (Fig. 5B). This is
consistent with previous evidence that the V-type H-ATPase
plays a key role in pH regulation in T. gondii (6) and, impor-
tantly, shows that the parasites that had been maintained in the
presence of ATc for 2 days were still actively maintaining their
resting pH (and, hence, were metabolically active) at the time
point at which all of our fluorometric assays were performed.
The spiroindolone cipargamin is one of a structurally diverse
range of antimalarial agents that inhibit P. falciparum growth
through an effect on ion homeostasis, attributed to inhibition
of Na efflux via PfATP4 (10, 13–16). The pyrazoleamide
PA21A050 is another such compound, structurally unrelated to
the spiroindolones (15). To determine whether PA21A050 can
inhibit T. gondii growth, we performed fluorescence growth
assays. The growth of T. gondii parasites was inhibited by
PA21A050 with an IC50 of 0.56 	 0.17 M (mean 	 S.D.; n  3;
Fig. 6A). This IC50 value is much higher than the previously
reported IC50 value for inhibition by PA21A050 of the prolifer-
ation of blood-stage P. falciparum parasites (0.7 nM (15)). We
investigated whether PA21A050, like cipargamin, impaired
Na homeostasis in T. gondii. As seen for cipargamin, addition
of PA21A050 (50 nM) to iHA-TgATP4 parasites grown in the
absence of ATc resulted in an increase in [Na]cyt (Fig. 6B).
Addition of PA21A050 to iHA-TgATP4 parasites grown in the
presence of ATc had little effect on the (already high) [Na]cyt
(Fig. 6B).
We next measured the effects of PA21A050 on resting pHcyt.
Again, as seen for cipargamin, addition of PA21A050 to iHA-
Figure 5. Na and pH regulation in TgATP4-expressing and TgATP4 knockdown parasites and the effect of cipargamin thereon. A and B, representative
traces showing the effects of cipargamin on [Na]cyt (A) and pHcyt (B) in iHA-TgATP4 parasites expressing TgATP4 (
ATc, black) and in parasites in which TgATP4
is knocked down (ATc, gray). Each trace is representative of at least three similar experiments. Parasites were suspended in physiological saline, and the
concentration of cipargamin added was 50 nM. Calibration traces for 20 mM and 130 mM Na are depicted to the left of the main traces. In B, concanamycin A
was added at a concentration of 100 nM to inhibit the plasma membrane V-type H-ATPase.
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TgATP4 parasites grown in the absence of ATc resulted in an
increase in resting pHcyt (Fig. 6C). No such increase was
observed in iHA-TgATP4 parasites grown in the presence of
ATc (Fig. 6C). The pyrazoleamide PA21A050 therefore affects
Na and pH homeostasis in a manner similar to cipargamin.
TgATP4 does not play a direct role in Ca2 regulation in
T. gondii
We next examined the role of TgATP4 in Ca2 regulation
using the Ca2-sensitive dye Fura-2. The resting cytosolic
[Ca2] ([Ca2]cyt) was similar in TgATP4-expressing and
TgATP4 knockdown parasites (Fig. 7A), and addition of cipar-
gamin had little effect on [Ca2]cyt in either case (Fig. 7A). We
also compared the ability of TgATP4-expressing and TgATP4
knockdown parasites to regulate their [Ca2]cyt in the presence
of increasing external [Ca2]. TgATP4-expressing and TgATP4
knockdown parasites were both able to regulate their [Ca2]cyt,
with [Ca2]cyt maintained at less than 150 nM in the presence of
external [Ca2] of up to 1 mM (the highest concentration tested;
Fig. 7B) for both strains and with no discernible difference
between them (p  0.39, unpaired t tests). Decreased expres-
sion of TgATP4 therefore has no significant effect on Ca2 reg-
ulation in these parasites.
Discussion
The first sequence analyses of PfATP4 led to annotation of
this protein as a Ca2 transporter (8, 33, 34), albeit one that was
phylogenetically distinct from other types of Ca2 ATPases
that had been categorized at that time. These studies also iden-
tified residues in PfATP4 that were proposed to be involved in
Ca2 binding (8, 33, 34). In a detailed phylogenetic analysis of
the 265-residue core region of 159 P-type ATPases, Axelsen
and Palmgren (24) placed PfATP4 in the type IIA subgroup of
P-type ATPases, most members of which are believed to trans-
port Ca2. However, few organisms belonging to the Apicom-
plexa or closely related phyla were included in their analysis. It
has also been suggested that PfATP4 might be an ENA (a type
IID P-type ATPase) (10). This suggestion was based on an
Figure 6. The effect of the pyrazoleamide PA21A050 on T. gondii growth, [Na]cyt, and pHcyt. A, the effect of various concentrations of the pyrazoleamide
PA21A050 on the growth of WT/Tomato parasites over the course of 7 days. The data shown are from a single experiment (with error bars showing the standard
deviation of triplicate measurements) and are representative of those obtained in three independent experiments. For clarity, the data points for 5 M and 10
M PA21A050 are not shown (they overlapped with those for 2.5 M PA21A050). Inset, the data for Day 5 shown in the main panel are plotted against the
concentration of PA21A050 to generate a dose–response curve. Where not shown, error bars fall within the symbols. B and C, representative traces showing the
effects of PA21A050 on [Na]cyt (B) and pHcyt (C) in iHA-TgATP4 parasites expressing TgATP4 (
ATc, black) and in parasites in which TgATP4 is knocked down
(ATc, gray). Each trace is representative of at least three similar experiments. Calibration traces for 20 mM and 130 mM Na are depicted to the left of the main
traces. Parasites were suspended in physiological saline, and PA21A050 was added at a concentration of 50 nM. Concanamycin A (C) was added at a concen-
tration of 100 nM to inhibit the V-type H-ATPase.
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eight-residue sequence in PfATP4 (849IVQSLKRK) with simi-
larity to a semiconserved motif in ENA ATPases (MIEALHRR
in ScENA1). Included in this motif is a triplet of positively
charged residues (KRK in PfATP4) that may be important for
Na transport (35). However, our analysis using the entire
P-type ATPase core sequence and a dataset containing repre-
sentatives from a variety of organisms, including members of
the Apicomplexa, Dinoflagellata, and Chromerida, reveal that
ATP4 proteins do not belong to one of the previously defined
subgroups of P-type ATPases but, rather, represent a distinct
subgroup. One consequence of this is that the function or sub-
strate specificity of the ATP4 proteins cannot be inferred from
their sequences and must be determined experimentally.
In this study, we found that cipargamin and PA21A050
induced a gradual, immediate-onset increase in both [Na]cyt
and pHcyt in T. gondii parasites expressing TgATP4. This mir-
rors the results of equivalent experiments in P. falciparum (10,
15). Notably, we observed no increases in [Na]cyt and pHcyt in
parasites in which TgATP4 was knocked down. Unlike
TgATP4-expressing parasites, which maintained a low [Na]cyt
of less than 20 mM in a solution with a high [Na] similar to that
found in serum and extracellular fluid (130 mM), TgATP4
knockdown parasites were unable to regulate their [Na]cyt and
had an internal [Na] similar to that of the extracellular solu-
tion. Together, these data are consistent with ATP4 function
being conserved between P. falciparum and T. gondii and pro-
vide genetic evidence that ATP4 proteins are cipargamin- and
PA21A050-sensitive pumps that extrude Na while importing
H. However, the possibility that the flux of H equivalents
that accompanies the transport of Na does not occur directly
via ATP4 cannot be excluded.
Extracellular parasites lacking TgATP4 lost viability more
rapidly than parasites expressing TgATP4. Upon prolonged
extracellular incubation ( 6 –12 h), these parasites appeared
swollen and frequently contained a large internal vacuole that
resembled the previously described plant-like vacuole of the
parasite (36). The plant-like vacuole has been associated with
parasite tolerance to salt stress (36), and its apparent increase in
size in extracellular parasites lacking TgATP4 may represent a
parasite response to the presence of high [Na]cyt. Our obser-
vation that extracellular T. gondii parasites swell upon deple-
tion of TgATP4 is in line with previous studies reporting that
P. falciparum parasites swell on exposure to compounds
believed to inhibit PfATP4 (9, 13, 15, 16). The observation that
the pHcyt of TgATP4-knockdown parasites was not signifi-
cantly different from that of TgATP4-expressing parasites indi-
cates that although, when present, TgATP4 imposes a signifi-
cant acid load on the parasite, it does not play a major role in
maintaining the normal resting pHcyt.
In the first experimental investigation of ATP4 function, it
was reported that membranes prepared from Xenopus oocytes
that had been injected with PfATP4 cRNA displayed greater
Ca2-ATPase activity than membranes from noninjected
oocytes (8). Others have since reported being unable to repro-
duce these findings (7, 37). Furthermore, addition to isolated
P. falciparum parasites of either the spiroindolone NITD246
(10) or the pyrazoleamide PA21A050 (15) (for which resistance
is mediated by mutation of PfATP4 (7, 15)) resulted in an
increase in [Na]cyt and pHcyt but no change in [Ca2]cyt (10,
15). Consistent with this, Ca2 did not stimulate the cipar-
gamin-sensitive ATPase activity measured in P. falciparum
membrane preparations (17). Our observations that cipar-
gamin had no significant effect on [Ca2]cyt in T. gondii and
that TgATP4 knockdown parasites were no less effective than
TgATP4-expressing parasites in regulating their [Ca2]cyt in
the face of increasing external [Ca2] provide further evidence
against a role for ATP4 in parasite Ca2 regulation. Our find-
ings that extracellular TgATP4 knockdown parasites cannot
maintain their plasma membrane Na gradient but maintain
tight control over their [Ca2]cyt suggest that the parasite is not
reliant on a plasma membrane Na/Ca2 exchanger to regulate
[Ca2]cyt. Orthologs of Na/Ca2 exchanger genes are lacking
in apicomplexan parasites, and to the extent of our knowledge,
there is no evidence, either from genomic or physiological data,
that T. gondii parasites possess a Na/Ca2 exchange system.
We conclude that TgATP4 is required for Na regulation but
Figure 7. Ca2 regulation in TgATP4-expressing and TgATP4 knockdown parasites and the effect of cipargamin. A, traces showing the effects of
cipargamin on [Ca2]cyt in iHA-TgATP4 parasites expressing TgATP4 (
ATc, black) and in parasites in which TgATP4 is knocked down (ATc, gray). The traces
are representative of those obtained in at least three similar experiments for each condition. The parasites were suspended in physiological saline, and the
concentration of cipargamin was 50 nM. Cyclopiazonic acid (CPA) was added at a concentration of 10 M to release the endoplasmic reticulum Ca2 store (59)
and confirm that the assay enabled the detection of changes in [Ca2]cyt. B, the [Ca
2]cyt in iHA-TgATP4 parasites expressing TgATP4 (
ATc, black symbols) and
in parasites in which TgATP4 was knocked down (ATc, gray symbols) in the presence of varying external [Ca2] ([Ca2]out). The data are averaged from those
obtained in four independent experiments performed on different days and are shown as the mean 	 S.D. The [Ca2]cyt values for TgATP4-expressing and
TgATP4 knockdown parasites were compared at each [Ca2]out using unpaired t tests. There was no significant difference between the [Ca
2]cyt in the two
strains at any of the [Ca2]out values tested.
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not for maintaining the normal cytosolic pH or Ca2 concen-
tration in T. gondii parasites.
Although a 50 nM concentration of either the spiroindolone
cipargamin or the pyrazoleamide PA21A050 was sufficient to
perturb pHcyt and [Na]cyt in extracellular tachyzoites (Figs. 5
and 6), much higher concentrations of each of these com-
pounds were needed to inhibit the proliferation of the parasite.
An IC50 of 1 M has been reported for inhibition of the prolif-
eration of T. gondii tachyzoites by cipargamin (23); for P. falcip-
arum, the IC50 is orders of magnitude lower ( 1 nM (7)). Sim-
ilarly, our testing of PA21A050, a structurally unrelated
PfATP4 inhibitor, for its effect on the proliferation of T. gondii
revealed an IC50 value more than 500-fold higher than that
reported for P. falciparum (15). Other antiplasmodial com-
pounds that are believed to inhibit PfATP4 (PfATP4-associated
compounds) also lack potency against T. gondii. Of the 28 anti-
plasmodial PfATP4-associated compounds identified in the
400-compound “Malaria Box” (14), all lacked potency against
T. gondii growth, with IC50 values greater than 14 M in all
cases (38). Thus, the available data indicate that, whereas in
P. falciparum cipargamin and PA21A050 both perturb ion
homeostasis and inhibit parasite proliferation in the nanomolar
range, in T. gondii the concentrations required to inhibit para-
site proliferation are much higher than those required to per-
turb ion homeostasis. Given that parasites can continue to pro-
liferate (albeit at a reduced rate) in the absence of TgATP4
expression, it is likely that cipargamin and PA21A050 exert
their growth-inhibitory effects on T. gondii via targets other
than TgATP4.
The differential susceptibility of P. falciparum and T. gondii
to growth inhibition by ATP4 inhibitors might be explained on
the basis of the different ionic conditions each of the two para-
sites experience in the course of their asexual cycles. Both cells
spend the majority of their asexual lytic cycles within host cells;
for T. gondii, these can be nucleated cells of any type, whereas
for P. falciparum (during the disease-causing stage of malaria),
the host cells are erythrocytes. Mammalian cells maintain a low
resting [Na]cyt. In the case of T. gondii-infected cells, there is
no evidence of significant perturbation of host cell ion homeo-
stasis; it is therefore presumed that the intracellular T. gondii
parasite is exposed to a low-[Na] environment, and the para-
site itself may therefore have little if any need to expend energy
on extruding Na ions, relying instead on the host cell’s
homeostatic mechanisms (Fig. 8). This might explain our find-
ing that the intracellular growth of T. gondii is not affected
when TgATP4 is knocked down. By contrast, while inside a
human erythrocyte, the asexual-stage P. falciparum parasite
induces profound changes to the permeability of the host eryth-
rocyte membrane, through so-called new permeability path-
ways, such that the membrane can no longer maintain a large
Na gradient, and [Na]cyt is increased to levels comparable
with that in the extracellular medium (Fig. 8) (39 –42). Conse-
quently, the P. falciparum parasite is exposed to a high-[Na]
environment for much of its 48 h occupancy of the erythrocyte
(from  20 h to 48 h post-invasion) (39). This might be
expected to render P. falciparum dependent on its Na extru-
sion mechanism for most of its intraerythrocytic cycle, and
hence particularly vulnerable to ATP4 inhibition (Fig. 8).
Knockdown and disruption of TgATP4 impaired, but did not
fully inhibit, T. gondii proliferation (Fig. 2D) (Fig. S4). We also
observed a defect in parasite virulence upon TgATP4 disrup-
tion (Fig. 4). A recent genome-wide CRISPR-based screen pro-
vided evidence that TgATP4 is important for normal T. gondii
growth, with TgATP4 ranked in the top 7% of the most impor-
tant genes in the parasite (“phenotype score” of 
4.77 (43)).
The growth and virulence defects we observed were perhaps
less pronounced than what may have been expected from the
genome-wide study. We observed no significant decreases in
invasion, intracellular growth, or egress upon TgATP4 knock-
down (Fig. 3, A–C), consistent with the growth defect being due
to an effect of TgATP4 knockdown on the parasite at another
part of the lytic cycle. The inability of TgATP4 knockdown par-
asites to regulate [Na]cyt is likely to make these parasites par-
ticularly sensitive to high-[Na] conditions, as prevail in the
extracellular medium (Fig. 8). Consistent with this, we found
that the decline in the viability of extracellular parasites over
time was more rapid for TgATP4 knockdown parasites than for
parasites expressing TgATP4 (Fig. 3D). We conclude that
TgATP4 is of particular importance in the extracellular stage of
the T. gondii lytic cycle, consistent with its proposed role in
mediating Na homeostasis in the parasite (Fig. 8).
In summary, this study provides genetic evidence that the
T. gondii ATP4 protein, TgATP4, plays an important role in the
extracellular stage of the lytic cycle of this parasite and func-
tions as a spiroindolone- and pyrazoleamide-sensitive Na/H
pump, acting to extrude Na from the parasite and maintain a
low [Na]cyt. The TgATP4 knockdown and disrupted lines pro-
vide tools for future functional studies to elucidate the impor-
tance of key residues in the ATP4 protein. For example, com-
plementing the inducible TgATP4 knockdown line described
here with mutant versions of TgATP4 (or with ATP4 variants
from other organisms) will enable the roles of individual ATP4
residues, both in the function of the protein and in conferring
resistance to PfATP4 antagonists, to be established.
Although Na-regulation in T. gondii and P. falciparum par-
asites is sensitive to nanomolar concentrations of ATP4 inhib-
itors, our results suggest key differences in the effects of ATP4
inhibition on the growth of the two parasite species. These dif-
ferences may be accounted for by the different exposure to
extracellular Na experienced by the two parasites. P. falcipa-
rum parasites are exposed to high external Na levels through-
out much of the intracellular phase of their intraerythrocytic
cycle, whereas exposure of T. gondii parasites to a high external
Na level is largely restricted to the extracellular phase of their
lytic cycle. Together with the observation that parasites lacking
TgATP4 have only a slight reduction in virulence, these findings
raise important reservations about the utility of TgATP4 as a
drug target in T. gondii.
Finally, our phylogenetic analysis indicates that ATP4 pro-
teins constitute a distinct subgroup within the type II P-type
ATPases, although proof that TgATP4 has a P-type ATPase
mechanism requires additional study. Nevertheless, our data
are consistent with ATP4-type ATPases having conserved roles
as ATP-dependent Na pumps in apicomplexans and their rel-
atives. The last common ancestors of apicomplexans, chromer-
ids, and dinoflagellates were free-living organisms that inhab-
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ited a marine environment (44), and it is conceivable that
ATP4-type ATPases first evolved a role in regulating [Na]cyt
in the high-Na ( 460 mM (45)) marine environment.
Experimental procedures
Ethics statement
Mouse studies examining T. gondii virulence were per-
formed according to procedures outlined in protocol A2016/
42, approved by the Australian National University Animal
Experimentation Ethics Committee.
Phylogenetic analysis of TgATP4
TgATP4 homologs and a representative selection of type II
P-type ATPases from a broad range of eukaryotic organisms
were aligned using ClustalX (46). The accession numbers for
the proteins in the dataset are in shown in Fig. 1. The “acces-
Figure 8. Schematic illustrating how differences in the lifestyles of P. falciparum and T. gondii might explain their different sensitivities to ATP4
inhibitors. P. falciparum trophozoites modify erythrocytes by inducing new permeability pathways (NPP) that mediate the net influx of Na across the
erythrocyte plasma membrane, exposing the intracellular parasite to a high external [Na] (130 mM). Uncharacterized “leak pathways” (represented by a
dotted line) mediate the influx of Na from the host cytosol into the parasite. The cipargamin- and PA21A050-sensitive ATP4 pump extrudes Na ions,
maintaining a low [Na] inside the parasite. The pump is proposed to import H as it exports Na, with the imported H being extruded from the parasite by
the concanamycin A–sensitive V-type H-ATPase (V-ATP) (10). T. gondii tachyzoites reside in host cells that maintain a low-[Na] environment ([Na] 10 mM)
through the action of the host plasma membrane Na/K-ATPase. Under these (low-intracellular-[Na]) conditions, the parasite is not reliant on its own Na
regulation mechanisms to maintain a low [Na]cyt. However, upon egress from their host cells, extracellular tachyzoites are exposed to the high-[Na
]
extracellular medium ([Na] 130 mM) and must actively extrude Na via ATP4 to maintain a low [Na]cyt.
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sion.version” sequence identifiers are provided for sequences
that are in the NCBI database. S. minutum accession numbers
were derived from the S. minutum genome browser (http://
marinegenomics.oist.jp/)7 (47). The Hematodinium sequences
are available in BioProject PRJNA317731 (48), and the C. velia
sequence CveI-6710 is available through the Uniprot database.
The editing software Jalview was used to trim the alignment to
the core sequence of 265 residues for P-type ATPases as defined
by Axelsen and Palmgren (24). The dataset was subjected to
maximum likelihood phylogenetic analysis using PHYLIP as
described previously (49). Bootstrap analysis, which provides a
statistical measure of confidence in the nodes of the phyloge-
netic tree, was performed using 1000 replicates.
Host cell and parasite culture
T. gondii was cultured in human foreskin fibroblasts (a kind
gift from Holger Schlüter, Peter MacCallum Cancer Centre) in
DMEM supplemented with 1% (v/v) fetal calf serum, 200 M
L-glutamine, 50 units/ml penicillin, 50 g/ml streptomycin, 10
g/ml gentamicin, and 0.25 g/ml amphotericin B. Cells were
cultured at 37 °C in a humidified 5% CO2 incubator. Unless
stated otherwise, the type I TATi/ku80 strain was used as the
parental strain for the parasites generated in this study (50).
Where applicable, ATc (dissolved in ethanol) was added at a
final concentration of 0.5 g/ml, yielding a final ethanol con-
centration of 0.025% (v/v).
Generation of genetically modified T. gondii lines
To generate a 3 HA tag replacement in the TgATP4 locus,
we amplified the 3 region of the TgATP4 ORF using the prim-
ers 5-GACTGGATCCGACCCACATCGATTTTTGGA-
ATCC and 5-CATGCCTAGGGGCCATAATCGCCGGCG-
CTTTGGAAG. We digested the resultant product with BamHI
and AvrII and ligated this into the BglII and AvrII sites of the
vector pgCH (32). This vector was linearized with BglII, trans-
fected into TATi/ku80 strain parasites, and selected on chlor-
amphenicol as described previously (51). To generate the
TgATP4 knockdown parasite strain, we first amplified a 3 flank
region of the TgATP4 locus with the primers 5-GATCACCG-
GTATGGCGGCCCGAGCATCG and 5-GACTGCGGCCG-
CGAGAGGAGTTTTTCAACACATCGGC. We digested the
PCR product with AgeI and NotI and ligated this into the XmaI
and NotI sites of the vector pPR2-HA3 (52). We then amplified
a 5 flank region of the TgATP4 locus with the primers 5-
TGACGGGCCCCTGCTACAAGCGAGTCTATGGTGGC
and 5-GCATTTAATTAAGCTAGTGGATGCGTGGAGA-
AAGTCG. We digested this product with ApaI and PacI and
ligated this into the equivalent sites of the pPR2-HA3 vector
already harboring the 3 flank. We digested the resultant vector
with NotI, transfected into TATi/ku80 strain parasites, and
selected on pyrimethamine as described previously (51). This
generated the strain we termed iHA-TgATP4. To verify suc-
cessful integration of the iHA-TgATP4 construct into the
TgATP4 locus, we performed PCR screens with the primers
“screen fwd” (5-AATCGCATCCTCGGATCTTG) and
“screen rvs” (5-AAGAGACGTGCTTCGCAGAG) to detect
the presence of the native locus and the primers “t7s4 fwd”
(5-ACGCAGTTCTGCCAAGACG) and screen rvs to detect
the presence of the modified locus. To enable us to perform
fluorescence growth assays, we introduced a tandem dimeric
Tomato red fluorescent protein into the iHA-TgATP4 strain
as described previously (32). To complement the iHA-
TgATP4 strain with a constitutively expressed TgATP4, we
synthesized the TgATP4 gene (Sigma-Aldrich). The synthe-
sized gene harbored a 5 XmaI and a 3 PstI site. We digested
the synthesized gene with XmaI and PstI and ligated this into
the equivalent sites of the vector pUgCTTy (53), which
places the TgATP4 gene downstream of the -tubulin pro-
moter, and fused with an N-terminal 5Ty1 epitope tag
(generating a vector we termed pUgCTTy(TgATP4)). We
linearized this vector with MfeI, transfected into iHA-
TgATP4 parasites, and selected on chloramphenicol. All
parasite strains were cloned by limiting dilution before
characterization.
To generate a parasite strain in which the TgATP4 ORF was
disrupted, we adopted a CRISPR/Cas9-based genome editing
approach. Using Q5 site-directed mutagenesis (New England
Biolabs), we modified the pSAG::Cas9-U6::sgUPRT vector
(Addgene plasmid 54467 (54)) to express a gRNA targeting the
first exon of the TgATP4 ORF. We PCR-amplified this vector
using the primers 5-ACTTCCTCGAGCGCAGACGGGTTT-
TAGAGCTAGAAATAGCAAG (the underlined sequence
encodes the TgATP4 targeting region) and 5-AACTTGA-
CATCCCCATTTAC and circularized the PCR product
according to the manufacturer’s instructions (New England
Biolabs). The resultant vector co-expresses the TgATP4-target-
ing gRNA and Cas9-GFP. We transfected this vector into type I
RH/hxgprt/Tomato strain parasites (32) and cloned GFP-
positive parasites 3 days after transfection. A mutant clone con-
taining a frameshift mutation (a 113-bp insertion) was identi-
fied and further verified by direct Sanger sequencing of the
TgATP4 locus. The resultant strain, termed atp434 –1338, was
complemented by integration of the pUgCTTy(TgATP4) vec-
tor as described above.
Immunofluorescence assays and Western blotting
Immunofluorescence assays (IFAs) and Western blots were
performed as described previously (28). For IFAs, we used
monoclonal rat anti-HA (1:500 dilution; clone 3F10, Roche)
and monoclonal mouse anti-TgP30 (1:1000; clone TP3, Abcam,
catalog no. ab8313) as primary antibodies and anti-mouse
Alexa Fluor 546 (1:500; Thermo Fisher, catalog no. A-11030),
anti-mouse Alexa Fluor 488 (1:500; Thermo Fisher, catalog no.
A-11029), and anti-rat Alexa Fluor 488 (1:200; Thermo Fisher,
catalog no. A-11006) as secondary antibodies. Microscopy was
performed on a DeltaVision Elite system (GE Healthcare) using
an inverted IX71 microscope with a 100 UPlanSApo oil
immersion lens (Olympus). Images were taken using a Photo-
metrics CoolSNAP HQ2 camera and deconvolved and adjusted
for contrast and brightness using SoftWoRx Suite 2.0 software.
For Western blotting, we used monoclonal rat anti-HA (1:500
dilution; clone 3F10, Roche) and mouse anti-GRA8 (1:10,000
dilution; a kind gift from Gary Ward, University of Vermont
7 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party– hosted site.
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(55)) as primary antibodies and horse radish peroxidase–
conjugated goat anti-rat (1:5000 dilution; Santa Cruz Biotech-
nology, catalog no. sc-2006) and goat anti-mouse (1:10,000
dilution; Santa Cruz Biotechnology, catalog no. sc-2005) as sec-
ondary antibodies.
Parasite growth, invasion, egress, viability, and virulence
assays
Fluorometic T. gondii growth assays were performed as
described previously (32). The parasites used in the experi-
ments shown in Fig. 2D had egressed naturally 2–12 h prior to
setting up the assays. Plaque assays were performed as
described previously (28), except that 2000 parasites were
added per flask. For intracellular growth assays, infected host
cells were washed in a high-[K] “intracellular” buffer (125 mM
KCl, 5 mM NaCl, 25 mM HEPES, 20 mM glucose, and 1 mM
MgCl2 (pH 7.4)). Parasites were then mechanically released
from host cells by passing infected cells through a 26-gauge
needle. Released parasites were filtered through a 3-m filter
and incubated on human foreskin fibroblast– containing cov-
erslips for 1 h. The intracellular buffer was removed by aspira-
tion and replaced with DMEM. Parasites were incubated a fur-
ther 4 h, during which they were able to invade host cells; then
parasites that had failed to invade were removed by washing the
host cells three times in DMEM. Infected host cells were cul-
tured for a further 20 h before fixation and counting of the
number of parasites in vacuoles. Parasites within at least 100
vacuoles were counted for each condition.
Parasites for invasion assays were prepared as for the
intracellular growth assays, except that parasites were incu-
bated in the presence of DMEM for 10 min to allow invasion
into host cells. Parasites were fixed in a solution of 3% (v/v)
paraformaldehyde and 0.1% (v/v) glutaraldehyde in PBS.
Extracellular parasites were labeled with monoclonal mouse
anti-TgP30 (1:1000; clone TP3, Abcam, catalog no. ab8313)
as a primary antibody and anti-mouse Alexa Fluor 488
(1:500; Thermo Fisher, catalog no. A-11029) as a secondary
antibody. At least 100 parasites encompassing 10 –15 fields
of view were counted for each assay.
Egress assays were performed as described previously (29).
Briefly, parasites were allowed to invade host cells for 1 h,
and then parasites that had not invaded were removed by
washing the host cells three times with DMEM. Parasites
were then grown with or without ATc (0.5 g/ml) for 30 h.
The culture medium was removed, infected host cells were
washed three times with DMEM, and stimulation medium
(DMEM supplemented with 10 mM HEPES and 2 M A23187
(Sigma-Aldrich)) was added to induce egress. After 3 min,
parasites were fixed using 4% (v/v) paraformaldehyde in PBS
and stained for IFAs using the primary antibody rabbit anti-
GAP45 (1:500 dilution, a kind gift from Con Beckers, Uni-
versity of North Carolina). Co-staining was performed with
rat anti-HA to confirm the reduced expression of HA-
TgATP4. Parasitophorous vacuoles were counted using the
fluorescence resulting from GAP45 staining. Egress was con-
sidered to have occurred from a vacuole when at least one
parasite was observed to have escaped.
To measure the viability of extracellular parasites, iHA-
TgATP4 and WT parasites were grown in the absence or pres-
ence of ATc for 2 days. Flasks containing infected host cells
were washed once in growth medium to remove extracellular
parasites, and then parasites were mechanically egressed from
host cells by passage through a 26-gauge needle. The released
parasites were filtered through a 3-m filter to remove host cell
debris and then incubated for 27 h in growth medium in a
humidified 5% CO2 incubator set to 37 °C. Parasite samples
were taken at 0, 4, 9, 20, and 27 h, pelleted by centrifugation at
12,000  g for 1 min, and then resuspended in a solution of 1
g/ml propidium iodide in PBS supplemented with 10 mM
D-glucose. Samples were incubated at room temperature in the
dark for 20 min and then analyzed by flow cytometry on an LSR
II flow cytometer (BD Biosciences). Viable parasites were gated
based on forward scatter, side scatter, and propidium iodide
fluorescence and analyzed using FlowJo software.
To measure the effects of the disruption of the TgATP4 gene
on parasite virulence, we infected five 6- to 8-week-old female
BALB/c mice with 103 WT (RHhxprt/Tomato), atp434 –1338,
or atp434 –1338/cTy1-TgATP4 parasites. Parasites were intra-
cellular at the time of preparation and were manually
egressed by passage through a 26-gauge needle. After cen-
trifugation at 1500  g for 10 min to sediment the parasites,
the parasites were resuspended in PBS and injected into mice
within 1 h of egress. Mice were monitored daily for symp-
toms of toxoplasmosis, and those exhibiting terminal symp-
toms were euthanized.
Fluorometric ion measurements
iHA-TgATP4 parasites, grown in 175-cm2 tissue culture
flasks for 2 days in the presence of either ATc (0.5 g/ml) or
solvent (0.025% (v/v) ethanol), were harvested by passage of
cultures through a 26-gauge needle. The parasites were then
passed through a 3-m filter to remove host cell debris and
centrifuged at 1500  g for 10 min. The supernatant medium
was removed, and the parasites were resuspended in 1 ml of
physiological saline (125 mM NaCl, 5 mM KCl, 25 mM HEPES,
20 mM glucose, and 1 mM MgCl2 (pH 7.10)) and then centrifuged
at 12,000  g for 1 min. The supernatant solution was removed,
and the parasites were resuspended again in physiological saline to
which the appropriate fluorescent dye was added.
[Na]cyt, pHcyt, and [Ca2]cyt were measured using the Na-
sensitive dye SBFI, the pH-sensitive dye BCECF, and the Ca2-
sensitive dye Fura-2, respectively. In all cases, parasites were
suspended in physiological saline and loaded using the ace-
toxymethyl ester forms of the dyes (Molecular Probes) at 37 °C.
In the case of SBFI, parasites were loaded with 6 M SBFI for 30
min in the presence of 0.1% w/v Pluronic F-127. For BCECF,
parasites were loaded for 14 min in the absence of Pluronic
F-127, and the BCECF concentration was 5 M. For Fura-2,
loading was performed over 30 min using 6 M Fura-2 and
0.04% (w/v) Pluronic F-127. The parasites were washed twice
after dye loading to remove extracellular dye.
In all cases, fluorescence measurements were performed at
37 °C on 5–10  107 parasites using a PerkinElmer LS 50B
fluorescence spectrometer with a dual excitation Fast Filter
accessory. Measurements were taken every 0.6 s, and a 6-s roll-
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ing average was applied to the data shown in Figs. 5, 6, B and C,
and 7A. In Figs. 5, 6, B and C, and 7A, the parasites were sus-
pended in physiological saline for the fluorescence measure-
ments. In Fig. 7B, parasites were suspended in a solution that
was identical to physiological saline except that it contained 1
mM EGTA (Ca2-free saline solution) or in Ca2-free saline
solution to which had been added sufficient CaCl2 to achieve a
final free [Ca2] of 1,100 or 1,000 M (Ca-EGTA Calculator
v1.3).
For [Na]cyt and [Ca2]cyt experiments, the dye-loaded cells
were excited at 340 nm and 380 nm, with fluorescence mea-
sured at 515 nm. For pHcyt experiments, the excitation wave-
lengths were 440 nm and 495 nm, and the emission wavelength
was 520 nm. [Ca2]cyt measurements were calibrated in situ
(56) using a Kd of 120 nM for the Fura-2/Ca2 complex. pHcyt
measurements were calibrated as described previously (3). Cell
number limitations prevented full calibration of Na measure-
ments; however, the fluorescence ratios corresponding to 130
mM Na and 20 mM Na were determined, essentially as
described previously (57, 58), by suspending parasites in cali-
bration salines containing either 130 mM or 20 mM Na and
adding the ionophores gramicidin, nigericin, and monensin
(each at 4 M). Segments of the calibration traces are shown
before the time courses presented in Figs. 5A and 6B.
HPLC measurements
An HPLC-based method described previously (11) for anal-
ysis of intracellular Na and K content in Plasmodium para-
sites was adapted here for use with T. gondii. Parasites were
harvested by passage of cultures through a 26-gauge needle.
The parasites were then passed through a 3-m filter to remove
host cell debris and centrifuged at 1500  g for 10 min.
The supernatant medium was removed, and the parasites were
washed and resuspended in a saline solution and then incu-
bated with cipargamin or DMSO (the conditions tested are
detailed in the legend for Fig. S5). The parasites were then sedi-
mented by centrifugation and washed three times (12,000  g, 1
min) in ice-cold wash buffer (150 mM magnesium acetate (pH
7.1)). The parasites were then resuspended in 100 l of lysis
buffer (40%/60% (v/v) 20 mM ammonium acetate (pH 5)/aceto-
nitrile) and centrifuged (16,000  g, 5 min) to remove insoluble
matter. The supernatant solution was transferred into a vial for
HPLC analysis, which was performed as described previously
(11).
Statistics
Data were tested for statistical significance using t tests (two-
tailed, unpaired) or one-way ANOVA, as stated in the relevant
sections. For the fluorescence-based assays of parasite growth
(for which data are shown in Fig. 2D), one-way ANOVA was
performed on the prenormalized data (fluorescence intensity
units, after subtraction of the background), and “experiment”
was used as a “blocking factor” to prevent any differences in
fluorescence intensity between different experiments from
eroding the precision of the test. Post hoc comparisons were
then performed using the least significant difference test. For
one-way ANOVAs performed without blocking, a post hoc
Tukey test was used.
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